Agile Therapeutics Priced, Nasdaq: AGRX
Biotech developing the first low-dose contraceptive patch.
Industry: Health Care
First Day Return: -7.7%
AGRX
Biotech developing the first low-dose contraceptive patch.
| IPO Data | |
|---|---|
| IPO Date | 05/22/2014 |
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $55 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| Underwriters |
|---|
| IPO Intelligence Only |
| Company Data | |
|---|---|
| Headquarters | Princeton, NJ, United States |
| Founded | 1997 |
| Employees at IPO | 11 |
| Website www.agiletherapeutics.com | |
IPO News for Agile Therapeutics
Agile Therapeutics (AGRX) Performance
